Common use of Certain Exercise Restrictions Clause in Contracts

Certain Exercise Restrictions. (a) Notwithstanding anything to the contrary set forth in this Warrant, at no time may a holder of this Warrant exercise this Warrant if the number of shares of Common Stock to be issued pursuant to such exercise would exceed, when aggregated with all other shares of Common Stock owned by such holder at such time, the number of shares of Common Stock which would result in such holder beneficially owning (as determined in accordance with Section 13(d) of the Securities Exchange Act of 1934, as amended, and the rules thereunder) in excess of 4.99% of all of the Common Stock outstanding at such time; provided, however, that upon a holder of this Warrant providing the Issuer with sixty-one (61) days notice (pursuant to Section 13 hereof) (the “Waiver Notice”) that such holder would like to waive this Section 7(a) with regard to any or all shares of Common Stock issuable upon exercise of this Warrant, this Section 7(a) will be of no force or effect with regard to all or a portion of the Warrant referenced in the Waiver Notice; provided, further, that this Section 8(a) shall be of no further force or effect during the sixty-one (61) days immediately preceding the expiration of the term of this Warrant.

Appears in 6 contracts

Samples: Waiver for Securities Purchase Agreement (Neoprobe Corp), Neoprobe Corp, Neoprobe Corp

AutoNDA by SimpleDocs

Certain Exercise Restrictions. (a) Notwithstanding anything to the contrary set forth in this Warrant, at no time may a holder of this Warrant exercise this Warrant if the number of shares of Common Stock to be issued pursuant to such exercise would exceed, when aggregated with all other shares of Common Stock owned by such holder at such time, the number of shares of Common Stock which would result in such holder beneficially owning (as determined in accordance with Section 13(d) of the Securities Exchange Act of 1934, as amended, and the rules thereunder) in excess of 4.99% of all of the Common Stock outstanding at such time; provided, however, that upon a holder of this Warrant providing the Issuer with sixty-one (61) days notice (pursuant to Section 13 hereof) (the "Waiver Notice") that such holder would like to waive this Section 7(a) with regard to any or all shares of Common Stock issuable upon exercise of this Warrant, this Section 7(a8(a) will be of no force or effect with regard to all or a portion of the Warrant referenced in the Waiver Notice; provided, further, that this Section 8(a) shall be of no further force or effect during the sixty-one (61) days immediately preceding the expiration of the term of this Warrant.

Appears in 4 contracts

Samples: Voyant International CORP, Voyant International CORP, Voyant International CORP

Certain Exercise Restrictions. (a) Notwithstanding anything to the contrary set forth in this Warrant, at no time may a holder of this Warrant exercise this Warrant if the number of shares of Common Stock to be issued pursuant to such exercise would exceed, when aggregated with all other shares of Common Stock owned by such holder at such time, the number of shares of Common Stock which would result in such holder beneficially owning (as determined in accordance with Section 13(d) of the Securities Exchange Act of 1934, as amended, and the rules thereunder) in excess of 4.99% of all of the Common Stock outstanding at such time; provided, however, that upon a holder of this Warrant providing the Issuer with sixty-one (61) days notice (pursuant to Section 13 hereof) (the “Waiver Notice”) that such holder would like to waive this Section 7(a8(a) with regard to any or all shares of Common Stock issuable upon exercise of this Warrant, this Section 7(a8(a) will be of no force or effect with regard to all or a portion of the Warrant referenced in the Waiver Noticesuch notice; provided, further, that this Section 8(a8(b) shall be of no further force or effect during the sixty-one (61) days immediately preceding the expiration of the term of this Warrant.

Appears in 4 contracts

Samples: Commerce Energy Group, Inc., Commerce Energy Group, Inc., Implant Sciences Corp

Certain Exercise Restrictions. (a) Notwithstanding anything to the contrary set forth in this Warrant, at no time may a holder of this Warrant exercise this Warrant if the number of shares of Common Stock to be issued pursuant to such exercise would exceed, when aggregated with all other shares of Common Stock owned by such holder at such time, the number of shares of Common Stock which would result in such holder beneficially owning (as determined in accordance with Section 13(d) of the Securities Exchange Act of 1934, as amended, and the rules thereunder) in excess of 4.99% of all of the Common Stock outstanding at such time; provided, however, that upon a holder of this Warrant providing the Issuer with sixty-one (61) days notice (pursuant to Section 13 hereof) (the “Waiver Notice”) that such holder would like to waive this Section 7(a8(a) with regard to any or all shares of Common Stock issuable upon exercise of this Warrant, this Section 7(a8(a) will be of no force or effect with regard to all or a portion of the Warrant referenced in the Waiver Notice; provided, further, that this Section 8(a) shall be of no further force or effect during the sixty-one (61) days immediately preceding the expiration of the term of this Warrant.

Appears in 4 contracts

Samples: Neoprobe Corp, Neoprobe Corp, Neoprobe Corp

Certain Exercise Restrictions. (a) Notwithstanding anything to the contrary set forth in this Warrant, at no time may a holder of this Warrant exercise this Warrant if the number of shares of Common Stock to be issued pursuant to such exercise would exceed, when aggregated with all other shares of Common Stock owned by such holder at such time, the number of shares of Common Stock which would result in such holder beneficially owning (as determined in accordance with Section 13(d) of the Securities Exchange Act of 1934, as amended, and the rules thereunder) in excess of 4.999.999% of all of the Common Stock outstanding at such time; provided, however, that upon a holder of this Warrant providing the Issuer with sixty-one (61) days notice (pursuant to Section 13 hereof) (the “Waiver Notice”) that such holder would like to waive this Section 7(a) 8 with regard to any or all shares of Common Stock issuable upon exercise of this Warrant, this Section 7(a) 8 will be of no force or effect with regard to all or a portion of the Warrant referenced in the Waiver Notice; provided, further, that this Section 8(a) provision shall be of no further force or effect during the sixty-one (61) days immediately preceding the expiration of the term of this Warrant.

Appears in 3 contracts

Samples: Convertible Preferred Stock Purchase Agreement (Ortec International Inc), Ortec International Inc, Ortec International Inc

Certain Exercise Restrictions. (a) Notwithstanding anything to the contrary set forth in this Warrant, at no time may a holder of this Warrant exercise this Warrant if the number of shares of Common Stock to be issued pursuant to such exercise would exceed, when aggregated with all other shares of Common Stock owned by such holder at such time, the number of shares of Common Stock which would result in such holder beneficially owning (as determined in accordance with Section 13(d) of the Securities Exchange Act of 1934, as amended, and the rules thereunder) in excess of 4.994.999% of all of the Common Stock outstanding at such time; provided, however, that upon a holder of this Warrant providing the Issuer with sixty-one (61) days notice (pursuant to Section 13 hereof) (the "Waiver Notice") that such holder would like to waive this Section 7(a) with regard to any or all shares of Common Stock issuable upon exercise of this Warrant, this Section 7(a) will be of no force or effect with regard to all or a portion of the Warrant referenced in the Waiver Notice; provided, further, that this Section 8(a) provision shall be of no further force or effect during the sixty-one (61) days immediately preceding the expiration of the term of this Warrant.

Appears in 3 contracts

Samples: Urigen Pharmaceuticals, Inc., Urigen Pharmaceuticals, Inc., Urigen Pharmaceuticals, Inc.

Certain Exercise Restrictions. (a) Notwithstanding anything to the contrary set forth in this Warrant, at no time may a holder of this Warrant exercise this Warrant if the number of shares of Common Stock to be issued pursuant to such exercise would exceed, when aggregated with all other shares of Common Stock owned by such holder at such time, the number of shares of Common Stock which would result in such holder beneficially owning (as determined in accordance with Section 13(d) of the Securities Exchange Act of 1934, as amended, and the rules thereunder) in excess of 4.999.99% of all of the Common Stock outstanding at such time; provided, however, that upon a holder of this Warrant providing the Issuer with sixty-one (61) days notice (pursuant to Section 13 hereof) (the “Waiver Notice”) that such holder would like to waive this Section 7(a) 8 with regard to any or all shares of Common Stock issuable upon exercise of this Warrant, this Section 7(a) 8 will be of no force or effect with regard to all or a portion of the Warrant referenced in the Waiver Notice; provided, further, that this Section 8(a) shall be of no further force or effect during the sixty-one (61) days immediately preceding the expiration of the term of this Warrant.

Appears in 2 contracts

Samples: Valcent Products Inc., Valcent Products Inc.

Certain Exercise Restrictions. (a) Notwithstanding anything to the contrary set forth in this Warrant, at no time may a holder of this Warrant exercise this Warrant if the number of shares of Common Stock to be issued pursuant to such exercise would exceed, when aggregated with all other shares of Common Stock owned by such holder at such time, the number of shares of Common Stock which would result in such holder beneficially owning (as determined in accordance with Section 13(d) of the Securities Exchange Act of 1934, as amended, and the rules thereunder) in excess of 4.994.999% of all of the Common Stock outstanding at such time; provided, however, that upon a holder of this Warrant providing the Issuer with sixty-one (61) days notice (pursuant to Section 13 hereof) (the "Waiver Notice") that such holder would like to waive this Section 7(a8(a) with regard to any or all shares of Common Stock issuable upon exercise of this Warrant, this Section 7(a8(a) will be of no force or effect with regard to all or a portion of the Warrant referenced in the Waiver Notice; provided, further, that this Section 8(a) provision shall be of no further force or effect (i) during the sixty-one (61) days immediately preceding the expiration of the term of this WarrantWarrant or (ii) upon the Holder's receipt of a Call Notice.

Appears in 1 contract

Samples: Ortec International Inc

Certain Exercise Restrictions. (a) Notwithstanding anything to the contrary set forth in this Warrant, at no time may a holder of this Warrant exercise this Warrant if the number of shares of Common Stock to be issued pursuant to such exercise would exceed, when aggregated with all other shares of Common Stock owned by such holder at such time, the number of shares of Common Stock which would result in such holder beneficially owning (as determined in accordance with Section 13(d) of the Securities Exchange Act of 1934, as amended, and the rules thereunder) in excess of 4.99% of all of the Common Stock outstanding at such time; provided, however, that upon a holder of this Warrant providing the Issuer with sixty-one (61) days notice (pursuant to Section 13 hereof) (the “Waiver Notice”) that such holder would like to waive this Section 7(a) with regard to any or all shares of Common Stock issuable upon exercise of this Warrant, this Section 7(a) will be of no force or effect with regard to all or a portion of the Warrant referenced in the Waiver Noticesuch notice; provided, further, that this Section 8(a7(a) shall be of no further force or effect during the sixty-one (61) days immediately preceding the expiration of the term of this Warrant.

Appears in 1 contract

Samples: Nexaira Wireless Inc.

Certain Exercise Restrictions. (a) Notwithstanding anything to the contrary set forth in this Warrant, at no time may a holder of this Warrant exercise this Warrant if the number of shares of Common Stock to be issued pursuant to such exercise would exceed, when aggregated with all other shares of Common Stock owned by such holder at such time, the number of shares of Common Stock which would result in such holder beneficially owning (as determined in accordance with Section 13(d) of the Securities Exchange Act of 1934, as amended, ; and the rules thereunder) in excess of 4.99% of all of the Common Stock outstanding at such time; provided, however, that upon a holder of this Warrant providing the Issuer with sixty-one (61) days notice (pursuant to Section 13 hereof) (the “Waiver Notice”) that such holder would like to waive this Section 7(a8(a) with regard to any or all shares of Common Stock issuable upon exercise of this Warrant, this Section 7(a8(a) will be of no force or effect with regard to all or a portion of the Warrant referenced in the Waiver Noticesuch notice; provided, further, that this Section 8(a8(b) shall be of no further force or effect during the sixty-one (61) days immediately preceding the expiration of the term of this Warrant.

Appears in 1 contract

Samples: Commerce Energy Group, Inc.

Certain Exercise Restrictions. (a) Notwithstanding anything to the contrary set forth in this Warrant, at no time may a holder of this Warrant exercise this Warrant if the number of shares of Common Stock to be issued pursuant to such exercise would exceed, when aggregated with all other shares of Common Stock owned by such holder at such time, the number of shares of Common Stock which would result in such holder beneficially owning (as determined in accordance with Section 13(d) of the Securities Exchange Act of 1934, as amended, and the rules thereunder) in excess of 4.99% of all of the Common Stock outstanding at such time; provided, however, that upon a holder of this Warrant providing the Issuer with sixty-one (61) days notice (pursuant to Section 13 hereof) (the "Waiver Notice") that such holder would like to waive this Section 7(a8(a) with regard to any or all shares of Common Stock issuable upon exercise of this Warrant, this Section 7(a8(a) will be of no force or effect with regard to all or a portion of the Warrant referenced in the Waiver Notice; provided, further, that this Section 8(a) shall be of no further force or effect during the sixty-one (61) days immediately preceding the expiration of the term of this Warrant.

Appears in 1 contract

Samples: Wits Basin Precious Minerals Inc

Certain Exercise Restrictions. (a) Notwithstanding anything to the contrary set forth in this Warrant, at no time may a holder of this Warrant exercise this Warrant if the number of shares of Common Stock to be issued pursuant to such exercise would exceed, when aggregated with all other shares of Common Stock owned by such holder at such time, the number of shares of Common Stock which would result in such holder beneficially owning (as determined in accordance with Section 13(d) of the Securities Exchange Act of 1934, as amended, and the rules thereunder) in excess of 4.99more than 4.999% of all of the Common Stock outstanding at such time; provided, however, that upon a holder of this Warrant providing the Issuer with sixty-one (61) days notice (pursuant to Section 13 hereof) (the "Waiver Notice") that such holder would like to waive this Section 7(a) with regard to any or all shares of Common Stock issuable upon exercise of this Warrant, this Section 7(a) will be of no force or effect with regard to all or a portion of the Warrant referenced in the Waiver Notice; provided, further, that this Section 8(a) provision shall be of no further force or effect during the sixty-one (61) days immediately preceding the expiration of the term of this Warrant.

Appears in 1 contract

Samples: Advanced Viral Research Corp

Certain Exercise Restrictions. (a) Notwithstanding anything to the contrary set forth in this Warrant, at no time may a holder of this Warrant exercise this Warrant if the number of shares of Common Stock to be issued pursuant to such exercise would exceed, when aggregated with all other shares of Common Stock owned by such holder at such time, the number of shares of Common Stock which would result in such holder beneficially owning (as determined in accordance with Section 13(d) of the Securities Exchange Act of 1934, as amended, and the rules thereunderAct) in excess of 4.99% of all of the Common Stock outstanding at such time; provided, however, that upon a holder of this Warrant providing the Issuer with sixty-one (61) days notice (pursuant to Section 13 hereof) (the “Waiver Notice”) that such holder would like to waive this Section 7(a) 8 with regard to any or all shares of Common Stock issuable upon exercise of this Warrant, this Section 7(a) 8 will be of no force or effect with regard to all or a portion of the Warrant referenced in the Waiver Noticesuch notice; provided, further, that this Section 8(a) 8 shall be of no further force or effect during the sixty-one (61) days immediately preceding the expiration of the term of this Warrant.

Appears in 1 contract

Samples: And Warrant Purchase Agreement (Implant Sciences Corp)

Certain Exercise Restrictions. (a) Notwithstanding anything to the contrary set forth in this Warrant, at no time may a holder Holder of this Warrant exercise this Warrant if the number of shares of Common Stock to be issued pursuant to such exercise would cause the number of shares of Common Stock owned by the Holder at such time to exceed, when aggregated with all other shares of Common Stock owned by such holder Holder at such time, the number of shares of Common Stock which would result in such holder Holder beneficially owning (as determined in accordance with Section 13(d) of the Securities Exchange Act of 1934, as amended, and the rules thereunder) in excess of 4.994.9% of all of the Common Stock outstanding at such time; providedPROVIDED, howeverHOWEVER, that upon a holder the Holder of this Warrant providing the Issuer with sixty-one (61) days notice (pursuant to Section 13 12 hereof) (the “Waiver Notice”"WAIVER NOTICE") that such holder Holder would like to waive this Section 7(a) with regard to any or all shares of Common Stock issuable upon exercise of this Warrant, this Section 7(a) will be of no force or effect with regard to all or a portion of the Warrant referenced in the Waiver Notice; providedPROVIDED, furtherFURTHER, that this Section 8(a) provision shall be of no further force or effect (i) during the sixty-one (61) days immediately preceding the expiration of the term of this WarrantWarrant or (ii) upon the Holder's receipt of a Call Notice.

Appears in 1 contract

Samples: Raptor Networks Technology Inc

Certain Exercise Restrictions. (a) Notwithstanding anything to the contrary set forth in this Warrant, at no time may a holder of this Warrant exercise this Warrant if the number of shares of Common Stock to be issued pursuant to such exercise would exceed, when aggregated with all other shares of Common Stock owned by such holder at such time, the number of shares of Common Stock which would result in such holder beneficially owning (as determined determined, in accordance with Section 13(d) of the Securities Exchange Act of 1934, as amended, and the rules thereunder) in excess of 4.99% of all of the Common Stock outstanding at such time; provided, however, that upon a holder of this Warrant providing the Issuer with sixty-one (61) days notice (pursuant to Section 13 hereof) (the “Waiver Notice”) that such holder would like to waive this Section 7(a8(a) with regard to any or all shares of Common Stock issuable upon exercise of this Warrant, this Section 7(a8(a) will be of no force or effect with regard to all or a portion of the Warrant referenced in the Waiver Noticesuch notice; provided, further, that this Section 8(a8(b) shall be of no further force or effect during the sixty-one (61) days immediately preceding the expiration of the term of this Warrant.

Appears in 1 contract

Samples: Commerce Energy Group, Inc.

Certain Exercise Restrictions. (a) Notwithstanding anything to the contrary set forth in this Warrant, at no time may a holder Holder of this Warrant exercise this Warrant if the number of shares of Common Stock to be issued pursuant to such exercise would cause the number of shares of Common Stock owned by the Holder at such time to exceed, when aggregated with all other shares of Common Stock owned by such holder Holder at such time, the number of shares of Common Stock which would result in such holder Holder beneficially owning (as determined in accordance with Section 13(d) of the Securities Exchange Act of 1934, as amended, and the rules thereunder) in excess of 4.994.9% of all of the Common Stock outstanding at such time; provided, however, that upon a holder the Holder of this Warrant providing the Issuer with sixtyseventy-one five (6175) days notice (pursuant to Section 13 hereof) (the "Waiver Notice") that such holder Holder would like to waive this Section 7(a8(a) with regard to any or all shares of Common Stock issuable upon exercise of this Warrant, this Section 7(a8(a) will be of no force or effect with regard to all or a portion of the Warrant referenced in the Waiver Notice; provided, further, that this Section 8(a) provision shall be of no further force or effect (i) during the sixtyseventy-one five (6175) days immediately preceding the expiration of the term of this WarrantWarrant or (ii) upon the Holder's receipt of a Call Notice.

Appears in 1 contract

Samples: Quantrx Biomedical Corp

AutoNDA by SimpleDocs

Certain Exercise Restrictions. (a) Notwithstanding anything to the contrary set forth in this Warrant, at no time may a holder of this Warrant exercise this Warrant if the number of shares of Common Stock to be issued pursuant to such exercise would exceed, when aggregated with all other shares of Common Stock owned by such holder at such time, the number of shares of Common Stock which would result in such holder beneficially owning (as determined in accordance with Section 13(d) of the Securities Exchange Act of 1934, as amended, and the rules thereunder) in excess of 4.99% of all of the Common Stock outstanding at such time; provided, however, that upon a holder of this Warrant providing the Issuer with sixty-one (61) days written notice (pursuant to Section 13 hereof) (the “Waiver Notice”) that such holder would like to waive this Section 7(a8(a) with regard to any or all shares of Common Stock issuable upon exercise of this Warrant, this Section 7(a8(a) will be of no force or effect with regard to all or a portion of the Warrant referenced in the Waiver Noticesuch notice; provided, further, that this Section 8(a8(b) shall be of no further force or effect during the sixty-one (61) days immediately preceding the expiration of the term of this Warrant.

Appears in 1 contract

Samples: Blast Energy Services, Inc.

Certain Exercise Restrictions. (a) Notwithstanding anything to the contrary set forth in this Warrant, at no time may a holder of this Warrant the Holder exercise this Warrant if the number of shares of Common Stock to be issued pursuant to such exercise would exceed, when aggregated with all other shares of Common Stock owned by such holder Holder at such time, the number of shares of Common Stock which would result in such holder beneficially owning (as determined in accordance with Section 13(d) of the Securities Exchange Act of 1934, as amended, and the rules thereunder) in excess of 4.994.999% of all of the Common Stock outstanding at such time; providedprovided , howeverhowever , that upon a holder of this Warrant providing the Issuer Corporation with sixty-one (61) days notice (pursuant to Section 13 hereof) (the "Waiver Notice") that such holder Holder would like to waive this Section 7(a) 8 with regard to any or all shares of Common Stock issuable upon exercise of this Warrant, this Section 7(a) 8 will be of no force or effect with regard to all or a portion of the Warrant referenced in the Waiver Notice; provided, further, that this Section 8(a) provision shall be of no further force or effect during the sixty-one (61) days immediately preceding the expiration of the term of this Warrant.

Appears in 1 contract

Samples: Warrant Agreement (Dc Brands International Inc)

Certain Exercise Restrictions. (a) Notwithstanding anything to the contrary set forth in this Warrant, at no time may a holder Holder of this Warrant exercise this Warrant if the number of shares of Common Stock to be issued pursuant to such exercise would cause the number of shares of Common Stock owned by the Holder at such time to exceed, when aggregated with all other shares of Common Stock owned by such holder Holder at such time, the number of shares of Common Stock which would result in such holder Holder beneficially owning (as determined in accordance with Section 13(d) of the Securities Exchange Act of 1934, as amended, and the rules thereunder) in excess of 4.994.9% of all of the Common Stock outstanding at such time; provided, however, that upon a holder the Holder of this Warrant providing the Issuer with sixty-one (61) days notice (pursuant to Section 13 hereof) (the "Waiver Notice") that such holder Holder would like to waive this Section 7(a8(a) with regard to any or all shares of Common Stock issuable upon exercise of this Warrant, this Section 7(a8(a) will be of no force or effect with regard to all or a portion of the Warrant referenced in the Waiver Notice; provided, further, that this Section 8(a) provision shall be of no further force or effect (i) during the sixty-one (61) days immediately preceding the expiration of the term of this WarrantWarrant or (ii) upon the Holder's receipt of a Call Notice.

Appears in 1 contract

Samples: Ortec International Inc

Certain Exercise Restrictions. (a) Notwithstanding anything to the contrary set forth in this Warrant, at no time may a holder of this Warrant exercise this Warrant if the number of shares of Common Stock to be issued pursuant to such exercise would exceed, when aggregated with all other shares of Common Stock owned by such holder at such time, the number of shares of Common Stock which would result in such holder beneficially owning (as determined in accordance with Section 13(d) of the Securities Exchange Act of 1934, as amended, and the rules thereunder) in excess of 4.999.999% of all of the Common Stock outstanding at such time; provided, however, that upon a holder of this Warrant providing the Issuer with sixty-one (61) days notice (pursuant to Section 13 hereof) (the “Waiver Notice”) that such holder would like to waive this Section 7(a7(b) with regard to any or all shares of Common Stock issuable upon exercise of this Warrant, this Section 7(a7(b) will be of no force or effect with regard to all or a portion of the Warrant referenced in the Waiver Notice; provided, further, that . If the Holder elects to exercise this Warrant and such exercise would result in such Holder beneficially owning (in accordance with Section 8(a13(d) shall be of no further force or effect during the sixty-one (61) days immediately preceding the expiration of the term Securities Exchange Act of this Warrant.1934, as amended, and the rules thereunder) more than 9.999% of all of the Common Stock

Appears in 1 contract

Samples: Convertible Preferred Stock Purchase Agreement (Ortec International Inc)

Certain Exercise Restrictions. (a) Notwithstanding anything to the contrary set forth in this Warrant, at no time may a holder Holder of this Warrant exercise this Warrant if the number of shares of Common Stock to be issued pursuant to such exercise would cause the number of shares of Common Stock owned by the Holder at such time to exceed, when aggregated with all other shares of Common Stock owned by such holder Holder at such time, the number of shares of Common Stock which would result in such holder Holder beneficially owning (as determined in accordance with Section 13(d) of the Securities Exchange Act of 1934, as amended, and the rules thereunder) in excess of 4.994.9% of all of the Common Stock outstanding at such time; providedPROVIDED, howeverHOWEVER, that upon a holder the Holder of this Warrant providing the Issuer with sixty-one (61) days notice (pursuant 13 to Section 13 hereof) (the “Waiver Notice”"WAIVER NOTICE") that such holder Holder would like to waive this Section 7(a8(a) with regard to any or all shares of Common Stock issuable upon exercise of this Warrant, this Section 7(a8(a) will be of no force or effect with regard to all or a portion of the Warrant referenced in the Waiver Notice; providedPROVIDED, furtherFURTHER, that this Section 8(a) provision shall be of no further force or effect (i) during the sixty-one (61) days immediately preceding the expiration of the term of this WarrantWarrant or (ii) upon the Holder's receipt of a Call Notice.

Appears in 1 contract

Samples: Raptor Networks Technology Inc

Certain Exercise Restrictions. (a) Section 7.1 4.99% Limit Notwithstanding anything to the contrary set forth in this Warrant, at no time may a the holder of this Warrant exercise this Warrant if the number of shares of Common Stock to be issued pursuant to such exercise would exceed, when aggregated with all other shares of Common Stock owned by such holder at such time, the number of shares of Common Stock which would result in such holder beneficially owning (as determined in accordance with Section 13(d) of the Securities Exchange Act of 1934, as amended, and the rules thereunder) in excess of 4.99% of all of the Common Stock outstanding at such time; provided, however, that upon a holder of this Warrant the Holder providing the Issuer with sixty-one (61) days days’ notice (pursuant to Section 13 10.3 hereof) (the "Waiver Notice") that such holder would like to waive this Section 7(a) 7.1 with regard to any or all shares of Common Stock issuable upon exercise of this Warrant, this Section 7(a) 7.1 will be of no force or effect with regard to all or a portion of the Warrant referenced in the Waiver Notice; provided, further, that this Section 8(a) provision shall be of no further force or effect during the sixty-one (61) days immediately preceding the expiration of the term of this Warrant.

Appears in 1 contract

Samples: VistaGen Therapeutics, Inc.

Certain Exercise Restrictions. (a) Notwithstanding anything to the contrary set forth in this Warrant, at no time may a holder Holder of this Warrant exercise this Warrant if the number of shares of Common Stock to be issued pursuant to such exercise would cause the number of shares of Common Stock owned by the Holder at such time to exceed, when aggregated with all other shares of Common Stock owned by such holder Holder at such time, the number of shares of Common Stock which would result in such holder Holder beneficially owning (as determined in accordance with Section 13(d) of the Securities Exchange Act of 1934, as amended, and the rules thereunder) in excess of 4.994.9% of all of the Common Stock outstanding at such time; provided, however, that upon a holder the Holder of this Warrant providing the Issuer with sixtyseventy-one five (6175) days notice (pursuant to Section 13 hereof) (the “Waiver Notice”) that such holder Holder would like to waive this Section 7(a8(a) with regard to any or all shares of Common Stock issuable upon exercise of this Warrant, this Section 7(a8(a) will be of no force or effect with regard to all or a portion of the Warrant referenced in the Waiver Notice; provided, further, that this Section 8(a) provision shall be of no further force or effect (i) during the sixtyseventy-one five (6175) days immediately preceding the expiration of the term of this WarrantWarrant or (ii) upon the Holder’s receipt of a Call Notice.

Appears in 1 contract

Samples: Quantrx Biomedical Corp

Certain Exercise Restrictions. (a) Notwithstanding anything to the contrary set forth in this Warrant, at no time may a holder Holder of this Warrant exercise this Warrant if the number of shares of Common Warrant Stock to be issued pursuant to such exercise would exceed, when aggregated with all other shares of Common Stock owned by such holder Holder at such time, the number of shares of Common Stock which would result in such holder Holder beneficially owning (as determined in accordance with Section 13(d) of the Securities Exchange Act of 1934, as amended, and the rules thereunder) in excess of 4.99% of all of the Common Stock outstanding at such time; provided, however, that upon a holder Holder of this Warrant providing the Issuer with sixty-one (61) days notice (pursuant to Section 13 hereof) (the “Waiver Notice”) that such holder Holder would like to waive this Section 7(a8(a) with regard to any or all shares of Common Stock issuable upon exercise of this Warrant, this Section 7(a8(a) will be of no force or effect with regard to all or a portion of the Warrant referenced in the Waiver Notice; provided, further, that this Section 8(a) shall be of no further force or effect during the sixty-one (61) days immediately preceding the expiration of the term of this Warrant.

Appears in 1 contract

Samples: Echo Therapeutics, Inc.

Certain Exercise Restrictions. (a) Notwithstanding anything to the contrary set forth in this Warrant, at no time may a holder of this Warrant exercise this Warrant if the number of shares of Common Stock to be issued pursuant to such exercise would exceed, when aggregated with all other shares of Common Stock owned by such holder at such time, the number of shares of Common Stock which would result in such holder beneficially owning (as determined in accordance with Section 13(d) of the Securities Exchange Act of 1934, as amended, and the rules thereunder) in excess of 4.99% of all of the Common Stock outstanding at such time; provided, however, that upon a holder of this Warrant providing the Issuer with sixty-one (61) days notice (pursuant to Section 13 hereof) (the “Waiver Notice”) that such holder would like to waive this Section 7(a) with regard to any or all shares of Common Stock issuable upon exercise of this Warrant, this Section 7(a) will be of no force or effect with regard to all or a portion of the Warrant referenced in the Waiver Notice; provided, further, that this Section 8(a7(a) shall be of no further force or effect during the sixty-one (61) days immediately preceding the expiration of the term of this Warrant.

Appears in 1 contract

Samples: Navidea Biopharmaceuticals, Inc.

Time is Money Join Law Insider Premium to draft better contracts faster.